EGFR is involved in several pathways that contribute to cell survival in glioblastoma, including the PI3k/Akt/mTOR and Ras/Raf/MAPK pathways, and can be induced by glutamatergic signaling [42]. Here, AKT1 is linked to glioblastoma.